Dominic Piscitelli
Director of Finance/CFO bei ORIC PHARMACEUTICALS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Aktive Positionen von Dominic Piscitelli
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ORIC PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.09.2019 | - |
Public Communications Contact | - | - | |
CELYAD ONCOLOGY SA | Director/Board Member | 06.05.2020 | - |
Independent Dir/Board Member | 06.05.2020 | - |
Karriereverlauf von Dominic Piscitelli
Ehemalige bekannte Positionen von Dominic Piscitelli
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ANAPTYSBIO, INC. | Director of Finance/CFO | 11.01.2017 | 16.08.2019 |
Investor Relations Contact | 11.01.2017 | 16.08.2019 | |
MEDIVATION INC | Director of Finance/CFO | 01.09.2012 | 01.01.2017 |
Investor Relations Contact | 01.09.2012 | 01.01.2017 | |
Astellas Pharmaceuticals SA | Corporate Officer/Principal | 01.09.2011 | 01.09.2012 |
OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Treasurer | 01.01.2009 | 01.01.2011 |
Ausbildung von Dominic Piscitelli
Hofstra University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Belgien | 2 |
Griechenland | 2 |
Operativ
Director of Finance/CFO | 3 |
Investor Relations Contact | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ANAPTYSBIO, INC. | Health Technology |
CELYAD ONCOLOGY SA | Health Technology |
ORIC PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Astellas Pharmaceuticals SA |
- Börse
- Insiders
- Dominic Piscitelli
- Erfahrung